AUSTIN, Texas, April 24 /PRNewswire-FirstCall/ -- Luminex Corporation , a leading multiplex bioassay solutions provider, has announced plans for the annual Planet xMAP USA end-user technology symposium. Planet xMAP USA 2006 will be held in Dallas, Texas, May 15-17, at The Adolphus Hotel. The Planet xMAP symposium includes presentations and workshops utilizing Luminex’s industry-benchmark xMAP(R) technology in clinical diagnostics and life sciences research. Luminex will also host a similar event, Planet xMAP - Europe, October 3-4, 2006 in Amsterdam, The Netherlands.
James W. Jacobson, Ph.D., Vice President of Research & Development of Luminex Corporation, stated, “Planet xMAP is a symposium of best practices and innovative applications of our xMAP technology. It is a learning conference for both Luminex and our end-users with great, collaborative interaction among presenters and participants. We share ideas and experiences focused on multiplexing technology for better science as well as efficiency, economy and market growth.”
The keynote speaker for the Planet xMAP USA Symposium is Todd R. Golub, M.D., Harvard Medical School Associate Professor of Pediatrics, who will speak on his application of xMAP technology to study the role of MicroRNA in cancer. Other guest speakers include Thomas Joos, Ph.D., NMI Natural and Medical Sciences Institute at the University of Tuebingen - Biochemistry Department Head; Imran H. Khan, Ph.D., University of California, Davis - Associate Director, Clinical Proteomics Core; Rajeev K. Dhawan, Ph.D., Charles River Laboratories - Director, Diagnostic Reagents; German Pihan, M.D., Beth Israel Deaconess Medical Center - Director, Hematopathology Fellowship, Department of Pathology; Anna Lokshin, Ph.D., University of Pittsburgh Medical Center - Assistant Professor of Medicine and Pathology, University of Pittsburgh Cancer Institute Director; David Chan, Ph.D., Dartmouth-Hitchcock Medical Center - Project Assistant, Molecular Pathology ; Joel Tabb, Ph.D., Agave BioSystems - Principal Scientist; Kodumudi Venkateswaran, Ph.D., Radix BioSolutions - Vice President, Research & Business Development. Topics will include genetic disease, infectious disease, and biological warfare pathogen detection.
Planet xMAP 2006 features a dynamic program of leading industry speakers, workshops, discussion groups and networking events. For additional information regarding the Planet xMAP USA Symposium or to register online, please visit http://www.luminexcorp.com/planetxmap, call 512-219-8020 or e-mail agilger@luminexcorp.com.
About Luminex
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company’s xMAP system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company’s xMAP technology is sold worldwide and is already in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Luminex’s xMAP technology received the 2005 Clinical Diagnostics Technology of the Year Award from Frost & Sullivan. The Company was named in the 2005 Deloitte Fast 500 of fastest growing technology companies. Further information on Luminex Corporation or xMAP can be obtained on the Internet at http://www.luminexcorp.com.
Luminex Corporate Contact: Harriss T. Currie Vice President, Finance/Chief Financial Officer 512.219.8020 hcurrie@luminexcorp.com Luminex Media Contact: Sandra Oak Nsight Public Relations 321.591.1509 soakpr@earthlink.net
Luminex Corporation
CONTACT: Corporate, Harriss T. Currie, Vice President, Finance-ChiefFinancial Officer of Luminex Corporation, +1-512-219-8020, orhcurrie@luminexcorp.com; or Media, Sandra Oak of Nsight Public Relations,+1-321-591-1509, or soakpr@earthlink.net
